Journals / Erciyes Medical Journal / 2016 / Cilt: 38 - Sayı: 4

Increased Expression of E-cadherin, Endothelin-1, and CD68 in Preeclamptic Placentas

Pages
149–152
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In addition, the expression of CD68 was found to be markedly increased in preeclamptic placentas in comparison to control placentas.Conclusion: The increased expression of E-cadherin, endothelin-1, and CD68 may play an important role in impaired trophoblast invasion, endothelial dysfunction, and inadequate spiral remodeling, which are key factors involved in the pathogenesis of PE.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Preeclampsia (PE) is a complex pregnancy-specific disorder characterized by the onset of hypertension and proteinuria in the second trimester of pregnancy.
📊
Key Findings & Data:In this study, we aimed to investigate the expression levels of E-cadherin, endothelin-1, and CD68 in both preeclamptic and normal placentas.Materials and Methods: In this study, placentas after birth at 35-38 weeks were included.
💡
Conclusion & Impact:In addition, the expression of CD68 was found to be markedly increased in preeclamptic placentas in comparison to control placentas.Conclusion: The increased expression of E-cadherin, endothelin-1, and CD68 may play an important role in impaired trophoblast invasion, endothelial dysfunction, and inadequate spiral remodeling, which are key factors involved in the pathogenesis of PE.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Preeclampsia (PE) is a complex pregnancy-specific disorder characterized by the onset of hypertension and proteinuria in the second trimester of pregnancy. The pathogenesis of PE still remains unknown. Revealing the specific proteins involved in placental functions is important for a better understanding of the pathogenesis of PE. In this study, we aimed to investigate the expression levels of E-cadherin, endothelin-1, and CD68 in both preeclamptic and normal placentas.Materials and Methods: In this study, placentas after birth at 35-38 weeks were included. Ten preeclamptic placentas and 10 normal placentas were used. The expression levels of E-cadherin, endothelin-1, and CD68 were measured by western blot. Results: It was observed that the expression of E-cadherin and endothelin-1 was not at detectable levels in normal placentas; however, E-cadherin and endothelin-1 were observed to be highly expressed in preeclamptic placentas. In addition, the expression of CD68 was found to be markedly increased in preeclamptic placentas in comparison to control placentas.Conclusion: The increased expression of E-cadherin, endothelin-1, and CD68 may play an important role in impaired trophoblast invasion, endothelial dysfunction, and inadequate spiral remodeling, which are key factors involved in the pathogenesis of PE.

🔖

Cite This Article

KANDEMİR, S. İ., TEKİN, M. A., ALPAYCI, R. (2016). Increased Expression of E-cadherin, Endothelin-1, and CD68 in Preeclamptic Placentas. Erciyes Medical Journal, Cilt: 38 - Sayı: 4, 149–152. https://ajindex.com/articles/223496

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Hutcheon JA, Lisonkova S, Joseph KS. Epidemiology of pre-eclamp-sia and the other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol 2011
  2. 25(4): 391-403. [CrossRef] 2. Trogstad L, Magnus P, Stoltenberg C. Pre-eclampsia: Risk factors and causal models. Best Pract Res Clin Obstet Gynaecol 2011
  3. 25(3): 329-42. [CrossRef] 3. American College of Obstetricians and Gynecologists. Hypertension in Pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstet Gy-necol 2013
  4. 122(5): 1122-31. 4. Saleh L, Verdonk K, Visser W, van den Meiracker AH, Danser AH. The emerging role of endothelin-1 in the pathogenesis of pre-eclamp-sia. Ther Adv Cardiovasc Dis 2016
  5. 10(5): 282-93. [CrossRef] 5. Sak S, Erdemoğlu M, Ağaçayak E, Yalınkaya A, Gül T. Evaluation of serum Troponin I Levels in preeclampsia. Dicle Med J 2015
  6. 42(2): 186-91. [CrossRef] 6. Verdonk K, Visser W, Van Den Meiracker A, Danser AH. The renin-angiotensin-aldosterone system in pre-eclampsia: the delicate bal-ance between good and bad. Clin Sci (Lond) 2014
  7. 126(8): 537-44. [CrossRef] 7. Velicky P, Knöfler M, Pollheimer J. Function and control of human invasive trophoblast subtypes: Intrinsic vs. maternal control. Cell Adh Migr 2016
  8. 10(1-2): 154-62. [CrossRef] 8. Walentin K, Hinze C, Schmidt-Ott KM. The basal chorionic tropho-blast cell layer: An emerging coordinator of placenta development. Bioessays 2016
  9. 38(3): 254-65. [CrossRef] 9. Mutluay D. Essential transcription factors for mouse blastocyst stage embryos. Scientific Works. Series C. Veterinary Medicine 2015
  10. LXI(1): 35-40. 10. Walentin K, Hinze C, Schmidt-Ott KM. The basal chorionic tropho-blast cell layer: An emerging coordinator of placenta development. Bioessays 2016
  11. 38(3): 254-65. [CrossRef] 11. Chaiworapongsa T, Chaemsaithong P, Yeo L, Romero R. Pre-ec-lampsia part 1: current understanding of its pathophysiology. Nat Rev Nephrol 2014
  12. 10(8): 466-80. [CrossRef] 12. Schneider MR, Dahlhoff M, Horst D, Hirschi B, Trülzsch K, Müller-Höcker J, et al. A key role for E-cadherin in intestinal homeostasis and Paneth cell maturation. PLoS One 2010
  13. 5(12): e14325. [CrossRef] 13. Rich S, McLaughlin VV: Endothelin receptor blockers in cardiovascu-lar disease. Circulation 2003
  14. 108(18): 2184-90. [CrossRef] 14. Schiffrin EL, Intengan HD, Thibault G, Touyz RM. Clinical sig-nificance of endothelin in cardiovascular disease. Curr Opin Cardiol 1997
  15. 12(4): 354-67. 15. Gottfried E,